NEW YORK – Retired football players may get involved in the testing of a drug treating traumatic brain injuries.
Neuralstem, Inc., of Rockville, Md., says it's working with the National Football League Alumni Association to study the feasibility of testing the drug now in an early human trial for treating depression. In animal studies, the drug appeared to stimulate creation of brain cells.
The testing would require government approval.
Concern has mounted about brain injuries and disease in former NFL players, driven in part by some high-profile suicides. Thousands of former players are suing the league and its teams, saying that for years the NFL did not do enough to protect players from concussions.